Selective inhibition of persistent sodium current by F 15845 prevents ischaemia-induced arrhythmias

British Journal of Pharmacology

Volumn 161, Issue 1, 2010, Pages 79-91

  Pignier, C ^a   Rougier, J S ^b   Vie B ^a   Culie C ^a   Verscheure, Y ^c   Vacher, B ^a   Abriel, H ^b   Le Grand, B ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b UNIVERSITY OF BERN   (Switzerland)

^c CEPC   (France)

Author keywords

anti arrhythmia agents; F 15845; ion channels; ischaemia, pharmacology

Indexed keywords

ACONITINE; ANTIANGINA PECTORIS AGENT; ANTIARRHYTHMIC AGENT; F 15845; SODIUM CHANNEL; UNCLASSIFIED DRUG; VERATRIDINE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DEPOLARIZATION; DRUG EFFECT; GENETIC TRANSFECTION; GUINEA PIG; HEART ARRHYTHMIA; HEART ATRIUM; HEART MUSCLE ISCHEMIA; HEART PAPILLARY MUSCLE; HEART PROTECTION; HEART RATE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN CELL; MALE; MEMBRANE POTENTIAL; MICROELECTRODE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PURKINJE FIBER; RAT; SODIUM CURRENT;

ACONITINE; ACTION POTENTIALS; ANIMALS; ARRHYTHMIAS, CARDIAC; BENZOTHIEPINS; CELL LINE; HEART ATRIA; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PATCH-CLAMP TECHNIQUES; PURKINJE FIBERS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; SWINE; VERATRIDINE;

EID: 77955785877     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00884.x     Document Type: Article

References (41)

1. Antzelevitch C, Belardinelli L, Zygmunt AC, Burashnikov A, Di Diego JM, Fish JM et al. (2004). Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 110 : 904 910. (Pubitemid 39136212)
2. Belardinelli L, Shryock JC, Fraser H (2006). Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart 92 (Suppl. IV iv6 iv14.
3. Bennett PB, Yazawa K, Makita N, George AL Jr. (1995). Molecular mechanism for an inherited cardiac arrhythmia. Nature 376 : 683 685.
4. Boutjdir M, Restivo M, Wei Y, Stergiopoulos K, El-Sherif N (1994). Early afterdepolarization formation in cardiac myocytes: analysis of phase plane patterns, action potential, and membrane currents. J Cardiovasc Electrophysiol 7 : 609 620.
5. Carmeliet E (1987). Slow inactivation of the sodium current in rabbit cardiac Purkinje fibres. Pflugers Arch 408 : 18 26.
6. Coulombe A, Coraboeuf E, Malecot C, Deroubaix E (1985). Role of the 'Na window' current and other ionic currents in triggering early after-depolarizations and resulting re-excitation in Purkinje fibers. In : Zipes DP, Jalife J (eds). Cardiac Electrophysiology and Arrhythmias. Grune and Stratton : New York, pp. 43 49.
7. + channels promote pause-induced spontaneous diastolic activity in long QT syndrome Type 3 myocytes. Circ Res 99 : 1225 1232.
8. Gintant GA, Datyner NB, Cohen IS (1984). Slow inactivation of a tetrodotoxin-sensitive current in canine cardiac Purkinje fibers. Biophys J 45 : 509 512.
9. Haigney MC, Lakatta EG, Stern MD, Silverman HS (1994). Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading. Circulation 90 : 391 399.
10. Hale SL, Shryock JC, Belardinelli L, Sweeney M, Kloner RA (2008). Late sodium current inhibition as a new cardioprotective approach. J Mol Cell Cardiol 44 : 954 967.
11. Hammarstrom AK, Gage PW (2002). Hypoxia and persistent sodium current. Eur Biophys J 31 : 323 330.
12. Hasenfuss G, Maier LS (2008). Mechanism of action of the new anti-ischaemia drug ranolazine. Clin Res Cardiol 97 : 222 226.
13. Honerjäger P, Meissner A (1983). The positive inotropic effect of aconitine. Naunyn Schmiedebergs Arch Pharmacol 322 : 49 58.
14. Ju YK, Saint DA, Gage PW (1996). Hypoxia increases persistent sodium current in rat ventricular myocytes. J Physiol 497 : 337 341.
15. + current blockers. Am J Physiol 269 : H533 H540.
16. Le Grand B, Dordain-Maffre M, John GW (2000). Lubeluzole-induced prolongation of cardiac action potential in rabbit Purkinje Fibres. Fundam Clin Pharmacol 14 : 159 162.
17. Le Grand B, Pignier C, Létienne R, Cuisiat F, Rolland F, Mas A et al. (2008). Sodium late current blockers in ischaemia reperfusion: is the bullet magic? J Med Chem 51 : 3856 3866.
18. Lederer WJ, Tsien RW (1976). Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibers. J Physiol 263 : 73 100.
19. Maltsev VA, Undrovinas A (2008). Late sodium current in failing heart: friend or foe? Prog Biophys Mol Biol 96 : 421 451.
20. Noble D, Noble PJ (2006). Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload. Heart 92 : iv1 iv5.
21. Pignier C, Revenaz C, Rauly-Lestienne I, Cussac D, Delhon A, Gardette J et al. (2007). Direct protective effects of poly-unsaturated fatty acids, DHA and EPA, against activation of cardiac late sodium current: a mechanism for ischaemia selectivity. Basic Res Cardiol 102 : 553 564.
22. Pinet C, Algalarrondo V, Sablayrolles S, Le Grand B, Pignier C, Cussac D et al. (2008). Protease-activated receptor-1 mediates thrombin-induced persistent sodium current in human cardiomyocytes. Mol Pharmacol 73 : 1622 1631.
23. Shryock JC, Belardinelli L (2008). Inhibition of late sodium current to reduce electrical and mechanical dysfunction of ischaemic myocardium. Br J Pharmacol 153 : 1128 1132.
24. Song Y, Shryock JC, Wu L, Belardinelli L (2004). Antagonism by ranolazine of the pro-arrhythmic effect of increase late Ina in guinea pig ventricular myocytes. J Cardiovasc Pharmacol 44 : 192 199.
25. Song Y, Shryock JC, Wagner S, Maier LS, Belardinelli L (2006). Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther 318 : 214 222.
26. Song Y, Shryock JC, Belardinelli L (2008). An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes. Am J Physiol 294 : H2031 H2039.
27. Sossalla S, Wagner S, Rasenack EC, Ruff H, Weber SL, Schöndube FA et al. (2008). Ranolazine improves dysfunction in isolated myocardium from failing human hearts: role of late sodium current and intracellular ion accumulation. J Mol Cell Cardiol 45 : 32 43.
28. + channels in guinea-pig ventricular myocytes. Am J Physiol 264 : H454 H463.
29. Tamareille S, Le Grand B, John GW, Feuvray D, Coulombe A (2002). Anti-ischaemic compound KC 12291 prevents diastolic contracture in isolated atria by blockade of voltage-gated sodium channels. J Cardiovasc Pharmacol 40 : 346 355.
30. 2+ overload and impairs function in anoxic rat heart. J Mol Cell Cardiol 22 : 57 72.
31. Undrovinas AI, Fleidervish IA, Makielski JC (1992). Inward sodium current at resting potentials in single cardiac myocytes induced by the ischaemic metabolite lysophosphatidylcholine. Circ Res 71 : 1231 1241.
32. Undrovinas AL, Belardinelli L, Undrovinas NA, Sabbah HN (2006). Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current. J Cardiovasc Electrophysiol 17 : S169 S177.
33. Vacher B, Pignier C, Létienne R, Verscheure Y, Le Grand B (2009). F 15845 inhibits cardiac persistent sodium current and prevents angina. Br J Pharmacol 156 : 214 225.
34. Van Bemmelen MX, Rougier JS, Gavillet B, Apothéloz F, Daidié D, Tateyama M et al. (2004). Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination. Circ Res 95 : 284 291.
35. + overload. J Pharmacol Exp Ther 330 : 696 703.
36. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM et al. (1988). The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction and reperfusion. Cardiovasc Res 22 : 447 455.
37. + channel mutations in the congenital long QT syndrome. Proc Natl Acad Sci U S A 93 : 13200 13205.
38. Wasserstrom JA, Salata JJ (1988). Basis for tetrodotoxin and lidocaine effects on action potentials in dog ventricular myocytes. Am J Physiol 254 : H1157 H1166.
39. Wu J, Corr PB (1994). Palmitoyl carnitine modifies sodium currents and induces transient inward current in ventricular myocytes. Am J Physiol 266 : H1034 H1046.
40. Wu L, Shryock JC, Song Y, Li Y, Antzelevitch C, Belardinelli L (2004). Antiarrhythmic effects of ranolazine in a guinea-pig in vitro model of long-QT syndrome. J Pharmacol Exp Ther 310 : 599 605.
41. Zaza A, Belardinelli L, Shryock JC (2008). Pathophysiology and pharmacology of the cardiac 'late sodium current'. Pharmacol Ther 119 : 326 339.